Pacific Sun Financial Corp Reduces Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Pacific Sun Financial Corp trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB) by 11.8% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 5,147 shares of the financial services provider’s stock after selling 690 shares during the quarter. Pacific Sun Financial Corp’s holdings in iShares Biotechnology ETF were worth $749,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in IBB. Biltmore Family Office LLC lifted its holdings in shares of iShares Biotechnology ETF by 1,810.9% in the 4th quarter. Biltmore Family Office LLC now owns 10,032 shares of the financial services provider’s stock worth $1,363,000 after buying an additional 9,507 shares during the period. Security National Bank of SO Dak raised its position in shares of iShares Biotechnology ETF by 1.3% in the 4th quarter. Security National Bank of SO Dak now owns 10,201 shares of the financial services provider’s stock worth $1,386,000 after acquiring an additional 129 shares in the last quarter. Novak & Powell Financial Services Inc. bought a new position in shares of iShares Biotechnology ETF in the 4th quarter worth $1,559,000. Chicago Partners Investment Group LLC raised its position in shares of iShares Biotechnology ETF by 10.6% in the 4th quarter. Chicago Partners Investment Group LLC now owns 2,849 shares of the financial services provider’s stock worth $384,000 after acquiring an additional 273 shares in the last quarter. Finally, Counterweight Ventures LLC bought a new position in shares of iShares Biotechnology ETF in the 4th quarter worth $823,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 1.2 %

NASDAQ:IBB traded up $1.76 during mid-day trading on Friday, hitting $144.91. 384,579 shares of the company’s stock traded hands, compared to its average volume of 1,474,622. The company has a fifty day moving average of $145.10 and a 200 day moving average of $139.27. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $150.57.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.